Adverse drug events in adult patients leading to emergency department visits

Annals of Pharmacotherapy

Volumn 44, Issue 4, 2010, Pages 641-649

  Sikdar, Khokan C ^a,b   Alaghehbandan, Reza ^a   MacDonald, Don ^a   Barrett, Brendan ^c   Collins, Kayla D ^a   Donnan, Jennifer ^a   Gadag, Veeresh ^b  

^a Newfoundland and Labrador Centre for Health Information   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Adverse drug event (ADE); Emergency departments; Prevalence; Preventability; Severity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHOLESTEROL; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; GASTROINTESTINAL AGENT; HEMATOLOGIC AGENT; INSULIN; MINERAL; NARCOTIC AGENT; NITRATE; RESPIRATORY TRACT AGENT; THYROID HORMONE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VITAMIN; WARFARIN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEMATOLOGIC DISEASE; HOSPITAL; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC DISORDER; NAUSEA; NEUROLOGIC DISEASE; PHARMACIST; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; RANDOM SAMPLE; RASH; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; UNIVERSITY; VOMITING; WEIGHT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; DATA COLLECTION; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; NEWFOUNDLAND AND LABRADOR; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950611351     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M416     Document Type: Article

References (39)

1. Evans RS, Lloyd JF, Stoddard GJ, Nebeker JR, Samore MH. Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother 2005;39: 1161-1168 DOI 10.1345/aph.1E642 (Pubitemid 40943163)
2. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995;274:29-34.
3. Baker GR, Norton PG, Flintoft V, et al. The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004;170:1678-1686 (Pubitemid 38758745)
4. Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. Ann Emerg Med 2005;45:197-206. DOI 10.1016/j.annemergmed.2004.09.020
5. Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008;178:1563-1569 DOI 10.1503/cmaj.071594 (Pubitemid 351860342)
6. Juntti-Patinen L, Neuvoren PJ. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 2002;58:479-482 Doi 10.1007/s00228-002- 0501-2 (Pubitemid 35244922)
7. Alexopoulou A, Dourakis SP, Mantzoukis D, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Int Med 2008;19:505-510 DOI 10.1016/j.ejim.2007.06.030
8. Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother 2005;39:1169-1174 DOI 10.1345/aph.1E559 (Pubitemid 40943164)
9. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-311 (Pubitemid 27045011)
10. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155:1949-1956
11. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001;41:192-199
12. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother 1999;33:1252-1257 DOI 10.1345/aph.19062 (Pubitemid 30022801)
13. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004;140:795-801. (Pubitemid 38623529)
14. Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, Roberts M. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy 2006;26: 1578-1586 (Pubitemid 44704470)
15. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004;329:15-19 DOI 10.1136/bmj.329.7456.15 (Pubitemid 38869995)
16. McCaig LF, Burt CW. National hospital ambulatory medical care survey: 2001 emergency department summary. Adv Data 2003;335:1-29.
17. Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999.
18. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy 2002;22:915-923 (Pubitemid 34743441)
19. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med 2000;15:149-154
20. Hutchinson TA, Flegel KM, Kramer MS, Leduc DG, Kong HPK. Frequency, severity and risk factors for adverse drug reactions in adult outpatients: a prospective study. J Clin Epidemiol 1986;39:533-542
21. Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-948
22. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-1866
23. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004;3:306-314 DOI 10.1136/qshc.2004.010611 (Pubitemid 39070900)
24. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-1564 (Pubitemid 36437933)
25. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-1116
26. Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001;8:254-266 (Pubitemid 32428753)
27. Bates DW, Miller EB, Cullen DJ, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 1999;159:2553-2560
28. Bates DW. Frequency, consequences and prevention of adverse drug events. J Qual Clin Pract 1999;19:13-17 Doi 10.1046/j.1440-1762.1999.00285.x (Pubitemid 29111572)
29. Dean B. Adverse drug events: what's the truth? Qual Saf Health Care 2003;12:165-166 DOI 10.1136/qhc.12.3.165 (Pubitemid 36723940)
30. Peyriere H, Cassan S, Floutard E, et al. Adverse drug events associated with hospital admission. Ann Pharmacother 2003;37:5-11. Doi 10.1345/aph.1C126 (Pubitemid 36068590)
31. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001;38:666-671 DOI 10.1067/mem.2001.119456 (Pubitemid 33131567)
32. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reaction. JAMA 2003;289:1107-1116
33. Yee JL, Hasson NK, Schreiber DH. Drug-related emergency department visits in elderly veteran population. Ann Pharmacother 2005;39:1990-1995 DOI 10.1345/aph.1E541 (Pubitemid 41745941)
34. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-2724
35. Otero MJ, Domínguez-Gil A, Bajo AA, Maderuelo JA. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients - a comment. Pharmacotherapy 1999;19:1185-1187 (Pubitemid 29455943)
36. Guyatt GH, Devereaux PJ, Lexchin J, et al. A systematic review of studies comparing health outcomes in Canada and the United States. Open Med 2007;l.
37. Tuohy CH. Dynamics of a changing health sphere: the United States, Britain, and Canada. Health Affairs 1999;18:114-134
38. Woolhandler S, Campbell T, Himmelstein DU. Costs of health care administration in the United States and Canada. N Engl J Med 2003;349: 768-775 (Pubitemid 37010782)
39. Institute of Medicine. Insuring America's health: principles and recommendations. Washington, DC: National Academy Press, 2004.